Skip to main content
Top
Published in: Tobacco Induced Diseases 1/2015

Open Access 01-12-2015 | Research

Geographic trends of tobacco-related cancers in Cyprus

Authors: Paraskevi Farazi, Lina Lander, Pavlos Pavlou, Katherine Watkins, Lynne Le, Amr Soliman

Published in: Tobacco Induced Diseases | Issue 1/2015

Login to get access

Abstract

Background

Causal relationships have been previously established between smoking and various cancers. In Cyprus, 39 % of men and 14 % of women reported daily smoking in 2008. The objective of this study was to compare the incidence of tobacco-related cancers to all other cancers by district and rural–urban classification to understand the impact of tobacco in Cyprus.

Methods

Data on lung, urinary bladder, oral, pharyngeal, head/neck, and laryngeal cancers were obtained from the Cyprus Cancer Registry (1998–2008). There were 3,635 patients with tobacco-related cancers and 18,780 with non-tobacco cancers. Univariate analysis comparing tobacco-related cancers and all other cancers were conducted with regards to age at diagnosis, age groups, sex, smoking status, disease stage, and rural/urban status, with a p-value of 0.05 considered significant. Smoking prevalence, lung cancer, and bladder cancer rates of Cyprus were also compared to a number of other European countries.

Results

Patients with tobacco-related cancers were older than those with non-tobacco cancers (mean age 67.2 ± 12.4 vs. 62.4 ± 17.1, p < 0.0001). Among those with tobacco-related cancers, 80.1 % were male compared to 45.4 % males with other cancer types. The proportion of ever smokers was higher among males compared to females in urban and rural districts. Sub-districts 41 (Age Adjusted Rate (AAR) 41.9, 95 % CI: 35.7-48.1), 60 (AAR 40.3, 95 % CI: 35.2-45.3), and 50 (AAR 36.3, 95 % CI: 33.8-38.7) had the highest rates of tobacco-related cancers. The overall tobacco-related cancer rate was the highest among males in urban districts (AAR 60.8, 95 % CI: 58.2-63.5). Among tobacco-related cancers, lung cancer had the highest overall AAR (17.9 per 100,000) while head and neck cancer had the lowest overall AAR (5.3 per 100,000). Additionally, even though Cypriot males aged 65–69 years old exhibited higher smoking prevalence than other European countries, the overall lung and bladder cancer rates were lower in Cyprus.

Conclusion

Despite the high proportion of smokers in Cyprus, cancer rates are low compared to other countries. Future in-depth measurements of relevant risk factors and smoking exposure can help understand this phenomenon and provide insights for cancer prevention.
Literature
1.
go back to reference World Health Organization. WHO global report: mortality attributable to tobacco. Geneva: World Health Organization; 2012. Available at: http://www.who.int/tobacco/publications/surveillance/rep_mortality_attributable/en/. World Health Organization. WHO global report: mortality attributable to tobacco. Geneva: World Health Organization; 2012. Available at: http://​www.​who.​int/​tobacco/​publications/​surveillance/​rep_​mortality_​attributable/​en/​.​
2.
go back to reference Adhikari B, Kahende J, Malarcher A, Pechacek T, Tong V. Smoking- attributable mortality, years of potential life lost, and productivity losses- United States. 2000–2004. Atlanta: Morbidity and Mortality Weekly Report; 2008. Adhikari B, Kahende J, Malarcher A, Pechacek T, Tong V. Smoking- attributable mortality, years of potential life lost, and productivity losses- United States. 2000–2004. Atlanta: Morbidity and Mortality Weekly Report; 2008.
3.
go back to reference World Health Organization. World Health Organization: Tobacco Fact Sheet. 2014. Available at: http://www.who.int/mediacentre/factsheets/fs339/en/. World Health Organization. World Health Organization: Tobacco Fact Sheet. 2014. Available at: http://​www.​who.​int/​mediacentre/​factsheets/​fs339/​en/​.​
4.
go back to reference U.S. Department of Health and Human Services. The health consequences of smoking: a report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004. U.S. Department of Health and Human Services. The health consequences of smoking: a report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004.
5.
go back to reference World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Switzerland: World Health Organization; 2009. World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Switzerland: World Health Organization; 2009.
6.
go back to reference Kumar V, Abbas AK, Aster JC. Chapter 7: environmental and nutritional disease. In: Robbins basic pathology. 9th ed. Canada: Anonymous Elsevier; 2012. Kumar V, Abbas AK, Aster JC. Chapter 7: environmental and nutritional disease. In: Robbins basic pathology. 9th ed. Canada: Anonymous Elsevier; 2012.
7.
go back to reference World Health Organization. IARC monographs on the evaluation of carcinogenic risk to humans. Volume 83- Tobacco smoke and involuntary smoking. Lyon, France: World Health Organization, International agency for Research on Cancer; 2004. World Health Organization. IARC monographs on the evaluation of carcinogenic risk to humans. Volume 83- Tobacco smoke and involuntary smoking. Lyon, France: World Health Organization, International agency for Research on Cancer; 2004.
8.
go back to reference Han YY, Davis DL, Weissfeld JL, Dinse GE. Generational risks for cancers not related to tobacco, screening, or treatment in the United States. Cancer. 2010;116(4):940–8.PubMedCentralPubMedCrossRef Han YY, Davis DL, Weissfeld JL, Dinse GE. Generational risks for cancers not related to tobacco, screening, or treatment in the United States. Cancer. 2010;116(4):940–8.PubMedCentralPubMedCrossRef
9.
go back to reference Burns DM. Nicotine addiction. In: Kasper D, Braunwald E, Hauser S, Longo D, Jameson JL, Fauci AS, editors. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill Professional; 2004. Burns DM. Nicotine addiction. In: Kasper D, Braunwald E, Hauser S, Longo D, Jameson JL, Fauci AS, editors. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill Professional; 2004.
10.
go back to reference Vogazianos P, Fiala J, Vogazianos M. The influence of active maternal smoking during pregnancy on birth weights in Cyprus. Cent Eur J Public Health. 2005;13(2):78–84.PubMed Vogazianos P, Fiala J, Vogazianos M. The influence of active maternal smoking during pregnancy on birth weights in Cyprus. Cent Eur J Public Health. 2005;13(2):78–84.PubMed
11.
go back to reference Peto R, Lopez AD, Boreham J, Thun M, Heath Jr C. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet. 1992;339(8804):1268–78.PubMedCrossRef Peto R, Lopez AD, Boreham J, Thun M, Heath Jr C. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet. 1992;339(8804):1268–78.PubMedCrossRef
12.
go back to reference Observatory SPH. An atlas of tobacco smoking in Scotland: A report presenting estimated smoking prevalence and smoking attributable deaths within Scotland (Appendix 5). Scotland: NHS Health Scotland; 2007. Observatory SPH. An atlas of tobacco smoking in Scotland: A report presenting estimated smoking prevalence and smoking attributable deaths within Scotland (Appendix 5). Scotland: NHS Health Scotland; 2007.
13.
go back to reference Yang MC, Fann CY, Wen CP, Cheng TY. Smoking attributable medical expenditures, years of potential life lost, and the cost of premature death in Taiwan. Tob Control. 2005;14 Suppl 1:i62–70.PubMedCentralPubMedCrossRef Yang MC, Fann CY, Wen CP, Cheng TY. Smoking attributable medical expenditures, years of potential life lost, and the cost of premature death in Taiwan. Tob Control. 2005;14 Suppl 1:i62–70.PubMedCentralPubMedCrossRef
14.
go back to reference Karekla M, Symeou A, Tsangari H, Kapsou M, Constantinou M. Smoking prevalence and tobacco exposure among adolescents in Cyprus. Eur J Public Health. 2009;19(6):655–61.PubMedCrossRef Karekla M, Symeou A, Tsangari H, Kapsou M, Constantinou M. Smoking prevalence and tobacco exposure among adolescents in Cyprus. Eur J Public Health. 2009;19(6):655–61.PubMedCrossRef
15.
go back to reference Republic of Cyprus. Smoking in Cyprus. Cyprus: Department of Statistics and Research; 1989. Republic of Cyprus. Smoking in Cyprus. Cyprus: Department of Statistics and Research; 1989.
16.
go back to reference Republic of Cyprus. Smoking prevalence among Cypriot population. Cyprus: Department of Statistics and Research; 1999. Republic of Cyprus. Smoking prevalence among Cypriot population. Cyprus: Department of Statistics and Research; 1999.
17.
go back to reference Republic of Cyprus Statistical Service. Health Survey 2003. Nicosia: Printing Office of the Republic of Cyprus; 2005. Republic of Cyprus Statistical Service. Health Survey 2003. Nicosia: Printing Office of the Republic of Cyprus; 2005.
18.
go back to reference Republic of Cyprus Statistical Service. European Health Survey 2008. Nicosia: Printing Office of the Republic of Cyprus; 2010. Republic of Cyprus Statistical Service. European Health Survey 2008. Nicosia: Printing Office of the Republic of Cyprus; 2010.
19.
go back to reference Christophi CA, Kolokotroni O, Alpert HR, Warren CW, Jones NR, Demokritou P, et al. Prevalence and social environment of cigarette smoking in Cyprus youth. BMC Public Health. 2008;8:190-2458-8-190.CrossRef Christophi CA, Kolokotroni O, Alpert HR, Warren CW, Jones NR, Demokritou P, et al. Prevalence and social environment of cigarette smoking in Cyprus youth. BMC Public Health. 2008;8:190-2458-8-190.CrossRef
20.
go back to reference Cooter M, Soliman AS, Pavlou P, Demetriou A, Orphanides C, Kritioti E, et al. Incidence and time trends of cancer in Cyprus over 11 years (1998–2008). Tumori. 2015;101(1):8–15.PubMedCrossRef Cooter M, Soliman AS, Pavlou P, Demetriou A, Orphanides C, Kritioti E, et al. Incidence and time trends of cancer in Cyprus over 11 years (1998–2008). Tumori. 2015;101(1):8–15.PubMedCrossRef
21.
go back to reference Republic of Cyprus Ministry of Health. Cyprus Cancer Registry (CyCR) Report for the Triennial 1998–2000. Cyprus Cancer Registry, Cyprus. Republic of Cyprus Ministry of Health. Cyprus Cancer Registry (CyCR) Report for the Triennial 1998–2000. Cyprus Cancer Registry, Cyprus.
22.
go back to reference Republic of Cyprus Ministry of Health. MECC Joint Registration Project Cyprus Cancer Registry (CyCR) Report for 2008–2009 (Data 2003–2005). Cyprus: Cyprus Cancer Registry; 2009. Republic of Cyprus Ministry of Health. MECC Joint Registration Project Cyprus Cancer Registry (CyCR) Report for 2008–2009 (Data 2003–2005). Cyprus: Cyprus Cancer Registry; 2009.
23.
go back to reference Freedman LS, National Cancer Institute (U.S.), Middle East Cancer Consortium. Cancer incidence in four member countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) compared with US SEER. 2006; 1 online resource (xvi, 150 p.)-1 online resource (xvi, 150 p.). Freedman LS, National Cancer Institute (U.S.), Middle East Cancer Consortium. Cancer incidence in four member countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) compared with US SEER. 2006; 1 online resource (xvi, 150 p.)-1 online resource (xvi, 150 p.).
24.
go back to reference Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, et al. Cancer Incidence in Five Continents, Vol. X (electronic version). Lyon: IARC; 2013. Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, et al. Cancer Incidence in Five Continents, Vol. X (electronic version). Lyon: IARC; 2013.
25.
go back to reference Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980–2012. JAMA. 2014;311(2):183–92.PubMedCrossRef Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980–2012. JAMA. 2014;311(2):183–92.PubMedCrossRef
26.
go back to reference Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: a new WHO Standard. GPE Discussion Paper Series: No. 31. 2001; Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: a new WHO Standard. GPE Discussion Paper Series: No. 31. 2001;
27.
go back to reference Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, Maisonneuve P, et al. Tobacco smoking and cancer: a meta-analysis. Int J Cancer. 2008;122(1):155–64.PubMedCrossRef Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, Maisonneuve P, et al. Tobacco smoking and cancer: a meta-analysis. Int J Cancer. 2008;122(1):155–64.PubMedCrossRef
29.
go back to reference Steliga MA, Dresler CM. Epidemiology of lung cancer: smoking, secondhand smoke, and genetics. Surg Oncol Clin N Am. 2011;20(4):605–18.PubMedCrossRef Steliga MA, Dresler CM. Epidemiology of lung cancer: smoking, secondhand smoke, and genetics. Surg Oncol Clin N Am. 2011;20(4):605–18.PubMedCrossRef
30.
go back to reference Li FX, Robson PJ, Chen Y, Qiu Z, Lo Siou G, Bryant HE. Prevalence, trend, and sociodemographic association of five modifiable lifestyle risk factors for cancer in Alberta and Canada. Cancer Causes Control. 2009;20(3):395–407.PubMedCrossRef Li FX, Robson PJ, Chen Y, Qiu Z, Lo Siou G, Bryant HE. Prevalence, trend, and sociodemographic association of five modifiable lifestyle risk factors for cancer in Alberta and Canada. Cancer Causes Control. 2009;20(3):395–407.PubMedCrossRef
31.
go back to reference Wlodarczyk A, Raciborski F, Opoczynska D, Samolinski B, GATS PWG. Daily tobacco smoking patterns in rural and urban areas of Poland--the results of the GATS study. Ann Agric Environ Med. 2013;20(3):588–94.PubMed Wlodarczyk A, Raciborski F, Opoczynska D, Samolinski B, GATS PWG. Daily tobacco smoking patterns in rural and urban areas of Poland--the results of the GATS study. Ann Agric Environ Med. 2013;20(3):588–94.PubMed
32.
go back to reference Gikas A, Merkouris P, Skliros E, Sotiropoulos A. Urban–rural differences in smoking prevalence in Greece. Eur J Public Health. 2007;17(4):402.PubMedCrossRef Gikas A, Merkouris P, Skliros E, Sotiropoulos A. Urban–rural differences in smoking prevalence in Greece. Eur J Public Health. 2007;17(4):402.PubMedCrossRef
33.
go back to reference World Health Organization. WHO Report on the Global Tobacco Epidemic, 2013: Cyprus. Switzerland: World Health Organization; 2013. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2013: Cyprus. Switzerland: World Health Organization; 2013.
34.
go back to reference Hoshino Y, Mio T, Nagai S, Miki H, Ito I, Izumi T. Cytotoxic effects of cigarette smoke extract on an alveolar type II cell-derived cell line. Am J Physiol Lung Cell Mol Physiol. 2001;281(2):L509–16.PubMed Hoshino Y, Mio T, Nagai S, Miki H, Ito I, Izumi T. Cytotoxic effects of cigarette smoke extract on an alveolar type II cell-derived cell line. Am J Physiol Lung Cell Mol Physiol. 2001;281(2):L509–16.PubMed
35.
go back to reference Aoshiba K, Tamaoki J, Nagai A. Acute cigarette smoke exposure induces apoptosis of alveolar macrophages. Am J Physiol Lung Cell Mol Physiol. 2001;281(6):L1392–401.PubMed Aoshiba K, Tamaoki J, Nagai A. Acute cigarette smoke exposure induces apoptosis of alveolar macrophages. Am J Physiol Lung Cell Mol Physiol. 2001;281(6):L1392–401.PubMed
37.
go back to reference Alguacil J, Kogevinas M, Silverman DT, Malats N, Real FX, Garcia-Closas M, et al. Urinary pH, cigarette smoking and bladder cancer risk. Carcinogenesis. 2011;32(6):843–7.PubMedCentralPubMedCrossRef Alguacil J, Kogevinas M, Silverman DT, Malats N, Real FX, Garcia-Closas M, et al. Urinary pH, cigarette smoking and bladder cancer risk. Carcinogenesis. 2011;32(6):843–7.PubMedCentralPubMedCrossRef
38.
go back to reference Saikia BJ, Phukan RK, Sharma SK, Sekhon GS, Mahanta J. Interaction of XRCC1 and XPD gene polymorphisms with lifestyle and environmental factors regarding susceptibility to lung cancer in a high incidence population in North East India. Asian Pac J Cancer Prev. 2014;15(5):1993–9.PubMedCrossRef Saikia BJ, Phukan RK, Sharma SK, Sekhon GS, Mahanta J. Interaction of XRCC1 and XPD gene polymorphisms with lifestyle and environmental factors regarding susceptibility to lung cancer in a high incidence population in North East India. Asian Pac J Cancer Prev. 2014;15(5):1993–9.PubMedCrossRef
39.
go back to reference Steinau M, Saraiya M, Goodman MT, Peters ES, Watson M, Cleveland JL, et al. Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States. Emerg Infect Dis. 2014;20(5):822–8.PubMedCentralPubMedCrossRef Steinau M, Saraiya M, Goodman MT, Peters ES, Watson M, Cleveland JL, et al. Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States. Emerg Infect Dis. 2014;20(5):822–8.PubMedCentralPubMedCrossRef
40.
go back to reference Tornesello ML, Perri F, Buonaguro L, Ionna F, Buonaguro FM, Caponigro F. HPV-related oropharyngeal cancers: From pathogenesis to new therapeutic approaches. Cancer Lett. 2014;351(2):198–205. Tornesello ML, Perri F, Buonaguro L, Ionna F, Buonaguro FM, Caponigro F. HPV-related oropharyngeal cancers: From pathogenesis to new therapeutic approaches. Cancer Lett. 2014;351(2):198–205.
41.
go back to reference Truta-Popa LA, Dinu A, Dicu T, Szacsvai K, Cosma C, Hofmann W. Preliminary lung cancer risk assessment of exposure to radon progeny for Transylvania. Romania Health Phys. 2010;99(3):301–7.PubMedCrossRef Truta-Popa LA, Dinu A, Dicu T, Szacsvai K, Cosma C, Hofmann W. Preliminary lung cancer risk assessment of exposure to radon progeny for Transylvania. Romania Health Phys. 2010;99(3):301–7.PubMedCrossRef
42.
go back to reference Wender R, Fontham ET, Barrera Jr E, Colditz GA, Church TR, Ettinger DS, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013;63(2):107–17.PubMedCentralPubMedCrossRef Wender R, Fontham ET, Barrera Jr E, Colditz GA, Church TR, Ettinger DS, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013;63(2):107–17.PubMedCentralPubMedCrossRef
43.
go back to reference Gulati S, Mulshine JL. Lung cancer screening guidelines: common ground and differences. Transl Lung Cancer Res. 2014;3(3):131–8.PubMedCentralPubMed Gulati S, Mulshine JL. Lung cancer screening guidelines: common ground and differences. Transl Lung Cancer Res. 2014;3(3):131–8.PubMedCentralPubMed
44.
go back to reference Takahashi I, Matsuzaka M, Umeda T, Yamai K, Nishimura M, Danjo K, et al. Differences in the influence of tobacco smoking on lung cancer between Japan and the USA: possible explanations for the ‘smoking paradox’ in Japan. Public Health. 2008;122(9):891–6.PubMedCrossRef Takahashi I, Matsuzaka M, Umeda T, Yamai K, Nishimura M, Danjo K, et al. Differences in the influence of tobacco smoking on lung cancer between Japan and the USA: possible explanations for the ‘smoking paradox’ in Japan. Public Health. 2008;122(9):891–6.PubMedCrossRef
Metadata
Title
Geographic trends of tobacco-related cancers in Cyprus
Authors
Paraskevi Farazi
Lina Lander
Pavlos Pavlou
Katherine Watkins
Lynne Le
Amr Soliman
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Tobacco Induced Diseases / Issue 1/2015
Electronic ISSN: 1617-9625
DOI
https://doi.org/10.1186/s12971-015-0048-5

Other articles of this Issue 1/2015

Tobacco Induced Diseases 1/2015 Go to the issue